Navigation Links
Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center
Date:10/1/2008

starts with an assessment of risk factors, such as a woman's personal history of cancer, previous radiation treatments, family history of breast or ovarian cancer, and previous abnormal tests. Additional assessments delve deeper into the patient's medical and family history, and are reviewed by Dr. Heck and Callif-Daley. If further testing is necessary, the option of genetic testing will be presented, and Callif-Daley will meet with the patient and explain the advantages, disadvantages and limitations of genetic test results.

"Testing positive for a genetic mutation that predisposes you to breast cancer does not mean you will get breast cancer, and testing negative does not mean you won't get breast cancer," explains Callif-Daley. "There are many other factors that determine your overall risk, and we need to carefully examine the whole of a woman's health, not just individual pieces."

For women determined to be at higher risk, whether through genetic testing or other methods, surgery or medications may be recommended to reduce their risk for cancer. Additionally, a medical surveillance program will be developed to monitor for any occurrence of breast or related cancers. That may include more frequent clinical breast exams, ultrasound exams or MRI (magnetic resonance imaging) scans, along with digital mammograms.

Linda Blum's Story of Survival

Linda Blum, 54, of Clayton, OH, is a woman who wanted answers about her breast cancer risk. In May of 2005, she was diagnosed with breast cancer. Blum was a busy mom of four, wife and caregiver to her husband who was fighting throat cancer, in addition to serving as a cheerleading coach and school board president for the Northmont City Schools. She says she "had too much to live for" and wasn't going to take her diagnosis "lying down." Seven months later, after a lumpectomy, intensive chemotherapy and radiation, she was cancer free.

When she was originally diagnosed, no one in her family had
'/>"/>

SOURCE Good Samaritan Hospital
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
2. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
3. Gilbert Hospital Continues Cutting Edge Treatments
4. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
5. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
6. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
7. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
8. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
9. Hospital to Hold MRSA Briefing for Media and Community Leaders
10. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
11. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 Fujirebio Diagnostics Inc., a Malvern-based ... the Year by the Eastern Technology Council at ... in Philadelphia on Thursday, December 3, 2009. ... Philadelphia region,s largest technology and life sciences trade ... Technology and Life Sciences Community, the awards are ...
(Date:12/14/2009)... Calif., Dec. 14 Alexza Pharmaceuticals, Inc. (Nasdaq: ... its New Drug Application (NDA) for Staccato® loxapine (AZ-004) ... AZ-004 is an inhalation product candidate being developed for ... or bipolar disorder. The IND for Staccato ... 2005. ,, "AZ-004 has delivered a predictable and consistent ...
(Date:12/14/2009)... Zargis Medical Corp., a majority-owned subsidiary ... a spin-off from Siemens Corporate Research (NYSE: ... begun selling its award-winning Zargis Cardioscan(TM) system on ... its accompanying Bluetooth®-enabled electronic stethoscope were jointly named ... Innovation of the Year." Cardioscan is the ...
Breaking Medicine Technology:Fujirebio Diagnostics Named Life Sciences Company of the Year 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2MHA Announces Gloria Barr Esq as Vice President 26 General Counsel 54636 1MHA Announces Gloria Barr Esq as Vice President 26 General Counsel 54636 2Nucleix Researchers Discover DNA Evidence May Easily be Falsified 3A Company Develops New Detection Technology for Preventing Biological Identity The 13594 1Nucleix Researchers Discover DNA Evidence May Easily be Falsified 3A Company Develops New Detection Technology for Preventing Biological Identity The 13594 2Nucleix Researchers Discover DNA Evidence May Easily be Falsified 3A Company Develops New Detection Technology for Preventing Biological Identity The 13594 3Nucleix Researchers Discover DNA Evidence May Easily be Falsified 3A Company Develops New Detection Technology for Preventing Biological Identity The 13594 4Department of Health Releases Guidance on Novel H1N1 Influenza for Schools K 12 54633 1Department of Health Releases Guidance on Novel H1N1 Influenza for Schools K 12 54633 2Department of Health Releases Guidance on Novel H1N1 Influenza for Schools K 12 54633 3
... Cardium Therapeutics,(Amex: CXM ) and ... that,positive findings from a preclinical study, demonstrating ... hyperthermia (cooling) for the potential,treatment of acute ... by BioMed Central (BMC) Cardiovascular Disorders (2008, ...
... Assess Feasibility of Dose-sparing and ... Vaccination Against H5N1 Flu -, GAITHERSBURG, Md., April 15 ... has received approval from the,Department of Health and Human Services ... for use with an injected H5N1,influenza vaccine. This decision was ...
Other Medicine Technology:Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 2Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 3Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 4Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 5Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 6Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 7Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 8Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 9Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 10Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 11Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack 12Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 2Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 3Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 4
(Date:12/15/2009)... "The entire San Diego Hospice and The ... Sol Price on December 14, 2009. Mr. Price has ... and ethics in his business, community and personal life. ... truly understood the responsibility of philanthropy and the role ... live on through his countless philanthropic efforts. We extend ...
(Date:12/14/2009)... OAK BROOK, Ill., Dec. 15 In ... a larger role than ever. Now the University ... noteworthy resources, Value Analysis: Achieving Cost Efficiencies ... staff in these complex environments. These new materials, ... in the field, provide a practical guide to ...
(Date:12/14/2009)... -- Americold Realty Trust ("Americold") announced today that it ... the U.S. Securities and Exchange Commission (the "SEC") relating ... shares. The number of shares to be offered and ... been determined. The common shares to be sold in ... ,, The joint book-running managers of the offering ...
(Date:12/14/2009)... -- United Dental Care (also known as Culver ... top-notch dental care in Southern California. We provide treatments ... braces (orthodontics) and periodontal treatments. Beverly Hills Dentist ... are staffed with experienced and trusted dentists who provide ... (Dr. E) is one of these trusted dentists. He ...
(Date:12/14/2009)... ... La Jolla, Calif. (Vocus) -- The physicians at Scripps ... new chief of staff of the 372-bed facility. Dr. Sedwitz will ... 1, 2010. , , , , ,During his two-year term, Dr. ... administrative staff and its board of directors. Dr. Sedwitz will play ...
Breaking Medicine News(10 mins):Health News:San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price 2Health News:University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources 2Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2Health News:United Dental Care, Gentle Care, Trusted Dentists 2Health News:United Dental Care, Gentle Care, Trusted Dentists 3Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3
... SAN DIEGO, Dec. 3 /PRNewswire-FirstCall/ - MIGENIX Inc.,(TSX: ... for infectious,diseases, has received preliminary four-week interim results ... C virus ("HCV") treatment-naive,patients which indicate that celgosivir ... effects on the tolerability, pharmacokinetics,and viral kinetics when ...
... 3 /PRNewswire-FirstCall/-- Alfacell Corporation,(Nasdaq: ACEL ) today ... and,Webcast at 11 a.m. EST on Monday, Dec. ... chief executive officer, and Lawrence A. Kenyon,chief operating ... of Alfacell,s financial performance for the fiscal first ...
... Inc. (Amex: PLX ), noted today that ... which is used as,an enzyme replacement therapy for ... Promising Drugs Entering Phase III Trials in the ... published by Thomson Scientific. Thomson,Scientific, a part of ...
... with National Quality/Patient Safety Initiatives; Geared to Reducing ... Errors, Enhancing Operating Room Efficiencies, LAKE FOREST, ... provider of outsourced hospital compounded sterile preparations, is,offering ... devoted to reducing medication errors and improving OR,efficiencies. ...
... 3 No longer are helmets,enough for motorcyclists ... book, Motorcycle Cancer?, author Randall Dale,Chipkar considers motorcycle ... riders may have a higher risk for cancer ... legs," says,Chipkar. "Is it a paradox that thousands ...
... and their ... employees, CHICAGO, Dec. ... care costs and help employees,identify their health risks and cut back on ... smoking cessation,plans and counseling to discounted gym memberships and even acupuncture --,can ...
Other Medicine News:Health News:MIGENIX Reports Preliminary Celgosivir Viral Kinetics Study 2Health News:MIGENIX Reports Preliminary Celgosivir Viral Kinetics Study 3Health News:MIGENIX Reports Preliminary Celgosivir Viral Kinetics Study 4Health News:MIGENIX Reports Preliminary Celgosivir Viral Kinetics Study 5Health News:MIGENIX Reports Preliminary Celgosivir Viral Kinetics Study 6Health News:Alfacell to Host Fiscal First Quarter 2008 Financial Results Conference Call and Webcast 2Health News:Protalix BioTherapeutics' prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific 2Health News:Protalix BioTherapeutics' prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific 3Health News:PharMEDium Announces Availability of Pre-Filled Operating Room Perioperative Compounded Drugs 2Health News:Motorcycle Radiation May Be Linked to Cancer Risk 2Health News:Employee Health Includes Financial Health, Too 2
... B6 makes it possible to determine the,vitamin ... method. The kits includes all reagents in,ready ... of the samples with,exception of the columns. ... simultaneous handling of many analytes in a ...
ELISA kit for the quantitative determination of autoantibodies to tissue transglutaminase (tTG) in serum....
... Increased volume for use with 4, 8, or ... permits withdrawal of nearly all of the solution. ... solution. Made of natural virgin polystyrene containing no ... Sterilized by irradiation. Dimensions: 78 mm W x ...
Volume: 25 ml; Volume Graduation: 2/10 ml...
Medicine Products: